These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
739 related articles for article (PubMed ID: 9294650)
1. Human prostate tumor angiogenesis in nude mice: metalloprotease and plasminogen activator activities during tumor growth and neovascularization of subcutaneously injected matrigel impregnated with human prostate tumor cells. Wilson MJ; Sinha AA Anat Rec; 1997 Sep; 249(1):63-73. PubMed ID: 9294650 [TBL] [Abstract][Full Text] [Related]
2. Plasminogen activator and metalloprotease activities of Du-145, PC-3, and 1-LN-PC-3-1A human prostate tumors grown in nude mice: correlation with tumor invasive behavior. Wilson MJ; Sinha AA Cell Mol Biol Res; 1993; 39(8):751-60. PubMed ID: 7951414 [TBL] [Abstract][Full Text] [Related]
3. Human lymphoblastoid cells produce extracellular matrix-degrading enzymes and induce endothelial cell proliferation, migration, morphogenesis, and angiogenesis. Vacca A; Ribatti D; Iurlaro M; Albini A; Minischetti M; Bussolino F; Pellegrino A; Ria R; Rusnati M; Presta M; Vincenti V; Persico MG; Dammacco F Int J Clin Lab Res; 1998; 28(1):55-68. PubMed ID: 9594364 [TBL] [Abstract][Full Text] [Related]
4. Stromal cells promote angiogenesis and growth of human prostate tumors in a differential reactive stroma (DRS) xenograft model. Tuxhorn JA; McAlhany SJ; Dang TD; Ayala GE; Rowley DR Cancer Res; 2002 Jun; 62(11):3298-307. PubMed ID: 12036948 [TBL] [Abstract][Full Text] [Related]
5. Plasminogen activator system modulates invasive capacity and proliferation in prostatic tumor cells. Festuccia C; Dolo V; Guerra F; Violini S; Muzi P; Pavan A; Bologna M Clin Exp Metastasis; 1998 Aug; 16(6):513-28. PubMed ID: 9872599 [TBL] [Abstract][Full Text] [Related]
6. Role of the SIKVAV site of laminin in promotion of angiogenesis and tumor growth: an in vivo Matrigel model. Kibbey MC; Grant DS; Kleinman HK J Natl Cancer Inst; 1992 Nov; 84(21):1633-8. PubMed ID: 1279183 [TBL] [Abstract][Full Text] [Related]
7. RNA interference-directed knockdown of urokinase plasminogen activator and urokinase plasminogen activator receptor inhibits prostate cancer cell invasion, survival, and tumorigenicity in vivo. Pulukuri SM; Gondi CS; Lakka SS; Jutla A; Estes N; Gujrati M; Rao JS J Biol Chem; 2005 Oct; 280(43):36529-40. PubMed ID: 16127174 [TBL] [Abstract][Full Text] [Related]
9. Nicotine induces cyclooxygenase-2 and vascular endothelial growth factor receptor-2 in association with tumor-associated invasion and angiogenesis in gastric cancer. Shin VY; Wu WK; Chu KM; Wong HP; Lam EK; Tai EK; Koo MW; Cho CH Mol Cancer Res; 2005 Nov; 3(11):607-15. PubMed ID: 16317086 [TBL] [Abstract][Full Text] [Related]
10. Metastatic model for human prostate cancer using orthotopic implantation in nude mice. Stephenson RA; Dinney CP; Gohji K; Ordóñez NG; Killion JJ; Fidler IJ J Natl Cancer Inst; 1992 Jun; 84(12):951-7. PubMed ID: 1378502 [TBL] [Abstract][Full Text] [Related]
11. Reconstituted basement membrane (matrigel) enhances the growth of human glioma cell lines in nude mice. Akbasak A; Toevs CC; Laske DW J Neurooncol; 1996 Jan; 27(1):23-30. PubMed ID: 8699222 [TBL] [Abstract][Full Text] [Related]
13. Gabexate mesilate inhibits colon cancer growth, invasion, and metastasis by reducing matrix metalloproteinases and angiogenesis. Yoon WH; Jung YJ; Kim TD; Li G; Park BJ; Kim JY; Lee YC; Kim JM; Park JI; Park HD; No ZS; Lim K; Hwang BD; Kim YS Clin Cancer Res; 2004 Jul; 10(13):4517-26. PubMed ID: 15240544 [TBL] [Abstract][Full Text] [Related]
14. Osteoblast-derived TGF-beta1 modulates matrix degrading protease expression and activity in prostate cancer cells. Festuccia C; Angelucci A; Gravina GL; Villanova I; Teti A; Albini A; Bologna M Int J Cancer; 2000 Feb; 85(3):407-15. PubMed ID: 10652434 [TBL] [Abstract][Full Text] [Related]
15. Hemostatic gelatin sponge is a superior matrix to matrigel for establishment of LNCaP human prostate cancer in nude mice. Cui L; Chen P; Tan Z; Li W; Dong Z Prostate; 2012 Nov; 72(15):1669-77. PubMed ID: 22473906 [TBL] [Abstract][Full Text] [Related]
16. Plasminogen activator inhibitor-1 regulates tumor growth and angiogenesis. McMahon GA; Petitclerc E; Stefansson S; Smith E; Wong MK; Westrick RJ; Ginsburg D; Brooks PC; Lawrence DA J Biol Chem; 2001 Sep; 276(36):33964-8. PubMed ID: 11441025 [TBL] [Abstract][Full Text] [Related]
17. Altered tumor vessel maturation and proliferation in placenta growth factor-producing tumors: potential relationship to post-therapy tumor angiogenesis and recurrence. Taylor AP; Rodriguez M; Adams K; Goldenberg DM; Blumenthal RD Int J Cancer; 2003 Jun; 105(2):158-64. PubMed ID: 12673673 [TBL] [Abstract][Full Text] [Related]
18. ADAMTS1 alters blood vessel morphology and TSP1 levels in LNCaP and LNCaP-19 prostate tumors. Gustavsson H; Tesan T; Jennbacken K; Kuno K; Damber JE; Welén K BMC Cancer; 2010 Jun; 10():288. PubMed ID: 20546609 [TBL] [Abstract][Full Text] [Related]
19. Role of Wnt/beta-catenin signaling pathway in epithelial-mesenchymal transition of human prostate cancer induced by hypoxia-inducible factor-1alpha. Jiang YG; Luo Y; He DL; Li X; Zhang LL; Peng T; Li MC; Lin YH Int J Urol; 2007 Nov; 14(11):1034-9. PubMed ID: 17956532 [TBL] [Abstract][Full Text] [Related]
20. Selection of highly metastatic variants of different human prostatic carcinomas using orthotopic implantation in nude mice. Pettaway CA; Pathak S; Greene G; Ramirez E; Wilson MR; Killion JJ; Fidler IJ Clin Cancer Res; 1996 Sep; 2(9):1627-36. PubMed ID: 9816342 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]